HYPERKINETIC SYNDROME FOLLOWING LONG-TERM HALOPERIDOL TREATMENT - INVOLVEMENT OF DOPAMINE AND NORADRENALINE

被引:15
|
作者
JACKSON, DM
DUNSTAN, R
PERRINGTON, A
机构
关键词
D O I
10.1007/BF01253061
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:175 / 186
页数:12
相关论文
共 50 条
  • [31] EVIDENCE FOR ULTRASTRUCTURAL-CHANGES IN CORTICAL AXODENDRITIC SYNAPSES FOLLOWING LONG-TERM TREATMENT WITH HALOPERIDOL OR CLOZAPINE
    VINCENT, SL
    MCSPARREN, J
    WANG, RY
    BENES, FM
    NEUROPSYCHOPHARMACOLOGY, 1991, 5 (03) : 147 - 155
  • [32] A case of risperidone-associated neuroleptic malignant syndrome in a patient receiving long-term haloperidol treatment
    Wee, J. C. P.
    Wong, E.
    Annathurai, A.
    HONG KONG JOURNAL OF EMERGENCY MEDICINE, 2010, 17 (03) : 285 - 288
  • [33] LONG-TERM FOLLOW-UP OF HYPERKINETIC AND NON-HYPERKINETIC CHILDREN
    HOWELL, DC
    HUESSY, HR
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (03) : 360 - 360
  • [34] Haloperidol for long-term aggression in psychosis
    Khushu, Abha
    Powney, Melanie J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
  • [36] Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia
    Daniel, DG
    Wozniak, P
    Mack, RJ
    McCarthy, BG
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (01) : 61 - 69
  • [37] Haloperidol vs. atypical antipsychotics in the long-term treatment of schizophrenia
    Altamura, C.
    Mauri, M. C.
    Dell'Osso, B.
    Buoli, M.
    Dragogna, F.
    Lietti, L.
    Glick, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 213 - 213
  • [38] Long-term effects of tetrabenazine in hyperkinetic movement disorders
    Jankovic, J
    Beach, J
    NEUROLOGY, 1997, 48 (02) : 358 - 362
  • [39] Long-term effects of tetrabenazine in hyperkinetic movement disorders
    Jankovic, J
    Beach, J
    NEUROLOGY, 1996, 46 (02) : 22005 - 22005
  • [40] Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia
    Kasper, S
    Lerman, MN
    McQuade, RD
    Saha, A
    Carson, WH
    Ali, M
    Archibald, D
    Ingenito, G
    Marcus, R
    Pigott, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (04): : 325 - 337